Art

J-GLOBAL ID：201502263588345190   Reference number：15A0213418

Estimates of the prevalence of and current treatment practices for rheumatoid arthritis in Japan using reimbursement data from health insurance societies and the IORRA cohort (I)

健康保険組合とIORRAコホートからの償還データを用いた日本における関節リウマチの有病率推定と現行治療実践(I)

Author (5)： YAMANAKA Hisashi (Tokyo Women’s Medical Univ., Tokyo, JPN) ,  SUGIYAMA Naonobu (Pfizer Japan Inc., Tokyo, JPN) ,  INOUE Eisuke (Tokyo Women’s Medical Univ., Tokyo, JPN) ,  TANIGUCHI Atsuo (Tokyo Women’s Medical Univ., Tokyo, JPN) ,  MOMOHARA Shigeki (Tokyo Women’s Medical Univ., Tokyo, JPN)
Material： Modern Rheumatology  (Mod Rheumatol)
Volume： 24  Issue： 1  Page： 33-41  Publication year： 2014 
JST Material Number： L5142A  ISSN： 1439-7595  Document type： Article
Article type： 原著論文  Country of issue： United Kingdom (GBR)  Language： ENGLISH (EN)

Thesaurus term： human(primates) ,...
Semi thesaurus term： IORRA cohort study ,...

Register(free) or Log In to access     To see more with JDream III (charged).   {{ this.onShowAbsJLink("http://jdream3.com/lp/jglobal/index.html?docNo=15A0213418&from=J-GLOBAL&jstjournalNo=L5142A") }}

JST classification (1)： Musculoskeletal diseases  (GG03000T)

Substance index (1)： Methotrexate

Reference (31)：

• Yamanaka H, Seto Y, Tanaka E, Furuya T, Nakajima A, Ikari K, et al. Management of rheumatoid arthritis: the 2012 perspective. Mod Rheumatol. 2012. doi:10.1007/s10165-012-0702-1.
• Seto Y, Tanaka E, Inoue E, Nakajima A, Taniguchi A, Momohara S, et al. Studies of the efficacy and safety of methotrexate at dosages over 8 mg/week using the IORRA cohort database. Mod Rheumatol. 2011;21:579-93. doi:10.1007/s10165-011-0445-4.
• Singh JA, Furst DE, Bharat A, Curtis JR, Kavanaugh AF, Kremer JM, et al. 2012 update of the 2008 American College of Rheumatology recommendations for the use of disease-modifying antirheumatic drugs and biologic agents in the treatment of rheumatoid arthritis. Arthritis Care Res (Hoboken). 2012;64:625-39. doi:10.1002/acr.21641.
• Smolen JS, Landewe R, Breedveld FC, Dougados M, Emery P, Gaujoux-Viala C, et al. EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs. Ann Rheum Dis. 2010;69:964-75. doi:10.1136/ard.2009.126532.
• Imanaka T, Shichikawa K, Inoue K, Shimaoka Y, Takenaka Y, Wakitani S. Increase in age at onset of rheumatoid arthritis in Japan over a 30-year period. Ann Rheum Dis. 1997;56:313-6.

Terms in the title (8)： 健康保険 ,  組合 ,  IORRAコホート ,  日本 ,  関節リウマチ ,  有病率 ,  推定 ,  治療